|1.||Maurer, M: 3 articles (07/2009 - 12/2007)|
|2.||Hampel, F: 3 articles (04/2004 - 03/2003)|
|3.||Ratner, P: 3 articles (04/2004 - 03/2003)|
|4.||Ciprandi, Giorgio: 2 articles (01/2010 - 09/2007)|
|5.||Siebenhaar, F: 2 articles (07/2009 - 12/2007)|
|6.||Schmolke, J: 2 articles (07/2009 - 12/2007)|
|7.||Zuberbier, T: 2 articles (07/2009 - 12/2007)|
|8.||Magerl, M: 2 articles (07/2009 - 12/2007)|
|9.||Metz, M: 2 articles (07/2009 - 12/2007)|
|10.||Fortea, Josep: 2 articles (08/2008 - 05/2007)|
12/01/1991 - "Ebastine treatment produced a significant reduction in the incidence and severity of most symptoms associated with perennial rhinitis. "
10/01/2002 - "Following 2 weeks' treatment, no significant differences (p > or = 0.91) were found between the ebastine with and without food groups in the percentage change from baseline of daily "reflective" total rhinitis symptom scores (i.e., patients' assessment of severity over the previous 12 h), but both ebastine groups exhibited significantly greater reductions versus patients receiving placebo (p < 0.0001). "
03/01/2003 - "Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis."
01/01/2009 - "The aim of this study is to preliminarily evaluate IFN-gamma production by peripheral blood mononuclear cells (PBMNC) and clinical changes after a treatment with lyophilized ebastine in patients with persistent allergic rhinitis (PER). "
05/01/2008 - "The aim of the reported study was to evaluate the preferences of allergic rhinitis patients who were given either a placebo version of ebastine FDT or a placebo version of ebastine regular tablet (RT). "
|2.||Seasonal Allergic Rhinitis (Hay Fever)
12/01/1989 - "It is concluded that ebastine (10-40 mg daily) is an effective and well tolerated treatment for hayfever."
04/01/2002 - "[Clinical efficacy of Ebastine under placebo-controlled outdoors clinical study on cedar pollinosis]."
01/01/1996 - "The efficacy of the second generation antihistamine ebastine has been investigated in the treatment and prevention of seasonal allergic rhinitis (SAR). "
01/01/1996 - "Clinical efficacy of ebastine in the treatment and prevention of seasonal allergic rhinitis."
03/01/2003 - "In conclusion, the comparative analysis of the results from these three trials shows that ebastine is efficacious in the reduction of nasal congestion associated with seasonal allergic rhinitis. "
12/01/2008 - "In addition, ebastine was significantly more effective than placebo at relieving the symptoms of chronic idiopathic urticaria. "
09/01/2011 - "Ebastine in chronic spontaneous urticaria in higher doses."
07/01/2009 - "Prevention of signs and symptoms of dermographic urticaria by single-dose ebastine 20 mg."
12/01/2007 - "Acquired cold urticaria symptoms can be safely prevented by ebastine."
01/01/1996 - "Thus, these results, which show ebastine to be an effective and well tolerated agent, indicated that the drug should be considered for the first-line therapy of chronic urticaria."
|4.||Perennial Allergic Rhinitis
12/01/2008 - "Ebastine is a second-generation antihistamine which has been shown to be an effective treatment for both seasonal and perennial allergic rhinitis. "
06/01/1999 - "This double-blind, placebo-controlled, multicentre study investigated the ability of ebastine, 10 and 20 mg once daily, to control symptoms of perennial allergic rhinitis (PAR) over a 12-week period, and assessed additional benefits of the 20-mg dose. "
06/01/1999 - "A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. "
12/01/1991 - "Oral ebastine, 10 mg once daily for seven days, and placebo were compared as treatment for active perennial allergic rhinitis in 151 patients in a multicenter, randomized, double-blind trial. "
12/01/1991 - "Ebastine in perennial allergic rhinitis."
03/01/2000 - "The present field study shows that ebastine 20 mg given prophylactically is effective against immediate mosquito bite symptoms, and that it also significantly decreases pruritus associated with the delayed bite papules."
03/01/2000 - "Ebastine decreased significantly (p <0.001) the size of the bite lesion and pruritus at 15 min. Ebastine also had a significant effect (p<0.01) on pruritus at 2 and 24 h, and this effect was highly significant when the measurements at all 4 time points were pooled. "
03/01/2000 - "Ebastine 20 mg and placebo were given for 4 days in a cross-over fashion, and the size of the bite lesion and the intensity of pruritus (visual analogue scale) were measured at 15 min and 2, 6 and 24 h after the bites. "
07/01/1997 - "At 15 min ebastine decreased significantly the size of the bite lesion (p = 0.0017) and pruritus (p<0.0001). "
12/01/1989 - "Ebastine (19 patients) was more effective (P less than 0.05) than placebo (21 patients) against symptoms of running nose, itching nose, sneezing and blocked nose. "
|3.||Histamine Antagonists (Antihistamines)
|6.||Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)